Friday 6 November 2026 Export CSTL’s income statement to Excel — free account

Castle Biosciences, Inc.

Castle Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $344.2 million, up 3.66% from fiscal 2024.

Revenue: +23.9%
EPS: −550.0%
Free cash flow: +56.8%
Total debt: −59.9%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

32.44 1.76 −5.15%

Follow CSTL

Alert me

Market cap: $1.0B
P/E: 0.0×
Fwd P/E: −29.8×
Dividend yield: —
F-score: 3/9
Altman Z: 6.70
Beneish M: −3.49
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	4	3	3	3	+8 more TTM periods Free account
ROE Full definition →	(4.87%)	(4.20%)	(2.85%)	(5.21%)
ROA Full definition →	(4.03%)	(3.51%)	(2.45%)	(4.35%)
ROIC Full definition →	(3.63%)	(9.40%)	(9.90%)	(14.72%)
Return on Tangible Assets Full definition →	(5.74%)	(4.99%)	(3.37%)	(6.20%)
Average Days of Receivables Full definition →	50.43	49.39	45.38	46.00
Free Cash Flow per Share Full definition →	0.13	(0.01)	0.15	0.98
Free Cash Flow Full definition →	3.99	(0.45)	4.56	28.37
Capital Expenditures Full definition →	(35.75)	(43.09)	(43.69)	(35.98)
Other line items
Cash ROIC Full definition →	0.83%	(0.06%)	0.62%	3.63%
Accounts Receivable Turnover Full definition →	7.43	7.10	6.89	7.28
Accounts Payable Turnover Full definition →	6.80	7.11	6.39	5.55
Inventory Turnover Full definition →	9.09	8.58	8.69	7.73
Average Days of Payables Full definition →	55.83	43.43	73.01	96.15
Days of Inventory on Hand Full definition →	43.82	47.53	50.79	52.69
Tax Rate Full definition →	0.02	0.01	(0.27)	(0.18)
Research and Development Expense of Revenue Full definition →	15.46%	15.52%	15.79%	15.06%
Selling, General and Administrative Expense of Revenue Full definition →	66.70%	68.20%	69.31%	66.62%
Share Based Compensation of Revenue Full definition →	11.67%	12.56%	13.09%	13.33%
Interest Coverage Full definition →	(51.16)	(85.62)	(163.99)	(497.79)
Operating CF/Net income Full definition →	(1.73)	(2.20)	(3.76)	(2.66)
Depreciation/Fixed assets Full definition →	0.13	0.13	0.12	0.38
Capex/Depreciation Full definition →	(2.54)	(3.28)	(3.74)	(0.98)
Revenue per Share Full definition →	12.31	11.75	11.37	11.88
Operating CF per Share Full definition →	1.30	1.40	1.61	2.22
Capex per Share Full definition →	(1.17)	(1.42)	(1.46)	(1.24)
Capex to Sales Full definition →	0.09	0.12	0.13	0.10

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly